- Lobbying
- Lobbying by Blandford Biotech
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeffrey Carroll | Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone; Legislative Director, Rep. Frank Pallone; Legislative Assistant, Rep. Frank Pallone. |
John Jonas | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Government Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Government Issues
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Government Issues
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Government Issues
Registration
Issue(s) they said they’d lobby about: Advocacy for emergency use authorization of SARS-CoV-2 Rapid Antigen Detection Test and assistance in obtaining government contracts..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate